Clinical Trial

Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMD

Name: Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMD — clinical trial record (NCT05904028)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: AO

Active, Not Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

Home optical coherence tomography- guided treatment versus treat and extend for the management of neovascular age-related macular degeneration.

Protocol Amendment History 1 change

critical Trial status changed: Recruiting → Active, Not Recruiting 2026-07-08

Trial Details

NCT Number	NCT05904028
Lead Sponsor	Jaeb Center for Health Research Collaborators: National Institutes of Health (NIH), National Eye Institute (NEI), Juvenile Diabetes Research Foundation
Conditions	Neovascular Age-related Macular Degeneration
Enrollment	603 participants
Start Date	2023-11-09
Primary Completion	2027-07-30 (estimated)
Study Completion	2027-07-30 (estimated)
Updated on ClinicalTrials.gov	2026-07-07